Reactions Weekly

, Volume 1635, Issue 1, pp 96–96 | Cite as

Crizotinib

Development of crizotinib-resistance in lung adenocarcinoma: case report
Case report
  • 15 Downloads

Reference

  1. Dong H-J, et al. Response and acquired resistance to crizotinib in Chinese patients with lung adenocarcinomas harboring MET Exon 14 splicing alternations. Lung Cancer 102: 118-121, Dec 2016. Available from: URL: http://doi.org/10.1016/j.lungcan.2016.11.006 - ChinaCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations